Hyaluronic Acid Receptor-Mediated Nanomedicines and Targeted Therapy

Small Methods. 2024 Oct;8(10):e2400513. doi: 10.1002/smtd.202400513. Epub 2024 Jul 23.

Abstract

Hyaluronic acid (HA) is a naturally occurring polysaccharide found in the extracellular matrix with broad applications in disease treatment. HA possesses good biocompatibility, biodegradability, and the ability to interact with various cell surface receptors. Its wide range of molecular weights and modifiable chemical groups make it an effective drug carrier for drug delivery. Additionally, the overexpression of specific receptors for HA on cell surfaces in many disease states enhances the accumulation of drugs at pathological sites through receptor binding. In this review, the modification of HA with drugs, major receptor proteins, and the latest advances in receptor-targeted nano drug delivery systems (DDS) for the treatment of tumors and inflammatory diseases are summarized. Furthermore, the functions of HA with varying molecular weights of HA in vivo and the selection of drug delivery methods for different diseases are discussed.

Keywords: hyaluronic acid; nanomedicines; receptor‐targeted delivery.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Carriers / chemistry
  • Drug Delivery Systems
  • Humans
  • Hyaluronan Receptors / metabolism
  • Hyaluronic Acid* / chemistry
  • Inflammation / drug therapy
  • Nanomedicine*
  • Nanoparticles / chemistry
  • Neoplasms* / drug therapy

Substances

  • Hyaluronic Acid
  • Hyaluronan Receptors
  • Drug Carriers